PlainRecalls
LowClass IIICompleted

FDA Drug recall · Reported August 31, 2016

Remeven Cream, (50% Urea in a Cream Base), a) 5.0 oz (142 g) and b) 9.0 oz (255 g) tubes, Rx only, Manufactured by Sonar Products Inc, Carlstadt, NJ. Distributed by Stratus Pharmaceuticals Inc., Miami, FL.

Crystallization; Complaints that cream appears to have crystallized

Recall #
D-1464-2016
Affected scope
a) 12,345 tubes; b) 8,578 tubes
Initiated
May 26, 2016
Verify with FDA Drug →
View my saved recalls

Stratus Pharmaceuticals Inc recalled Remeven Cream, (50% Urea in a Cream Base), a) 5.0 oz (142 g) and b) 9.0 oz (255 g) tube… - a low-severity action.

Remeven Cream, (50% Urea in a Cream Base), a) 5.0 oz (142 g) and b) 9.0 oz (255 g) tube… was recalled by Stratus Pharmaceuticals Inc in August 31, 2016. Reason: Crystallization; Complaints that cream appears to have crystallized. Check the official notice for the remedy. Verify recall #D-1464-2016 with the FDA Drug before acting.

The recall

Stratus Pharmaceuticals Inc issued this low-severity FDA Drug recall-Crystallization; Complaints that cream appears to have crystallized.

Low
severity level
Class III
classification
August 31, 2016
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1464-2016 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-1464-2016) was formally reported on August 31, 2016, with the manufacturer initiating the action on May 26, 2016. It is classified under Low severity (Class III), with a current status of Completed. Stratus Pharmaceuticals Inc is listed as the recalling firm, operating out of Miami, FL. Federal records list the affected scope as a) 12,345 tubes; b) 8,578 tubes.

The documented reason for this recall is: Crystallization; Complaints that cream appears to have crystallized Distribution data in the federal record shows the product reached: Nationwide and PR. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 3 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Cosmetics & Personal Care recalls over time

Where this recall sits in its category - 1,360 cosmetics & personal care recalls on record

-1000100200300400 20052008201120142017202020232026 22
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Low

Affected scope

a) 12,345 tubes; b) 8,578 tubes

Related Recalls

6

3 from same agency

Product description

Remeven Cream, (50% Urea in a Cream Base), a) 5.0 oz (142 g) and b) 9.0 oz (255 g) tubes, Rx only, Manufactured by Sonar Products Inc, Carlstadt, NJ. Distributed by Stratus Pharmaceuticals Inc., Miami, FL.

Reason for recall

Crystallization; Complaints that cream appears to have crystallized

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Low (Class III)
Status Completed
Recall number D-1464-2016
Date reported August 31, 2016
Date initiated May 26, 2016
Recalling firm Stratus Pharmaceuticals Inc
Firm location Miami, FL
Affected scope a) 12,345 tubes; b) 8,578 tubes
Distribution Nationwide and PR

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-1464-2016) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Remeven Cream, (50% Urea in a Cream Base), a) 5.0 oz (142 g) and b) 9.0 oz (255 g) tubes, Rx only, Manufactured by Sonar Products Inc, Carlstadt, NJ. Distributed by Stratus Pharmaceuticals Inc., Miami, FL.. Recalled by Stratus Pharmaceuticals Inc. Units affected: a) 12,345 tubes; b) 8,578 tubes.
Why was this product recalled?
Crystallization; Complaints that cream appears to have crystallized
Which agency issued this recall?
This recall was issued by the FDA Drug on August 31, 2016. Severity: Low. Recall number: D-1464-2016.
Where was the recalled product distributed?
Distribution: Nationwide and PR.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-1464-2016) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Tiny Land Children's Play Tents Recalled Due to Risk of Inj… →

Browse all Cosmetics & Personal Care recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported August 31, 2016. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.